Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 3, 2016
Event: Entry into a Material Definitive Agreement involving the issuance of debt and equity warrants.
Key Financial Metrics
This filing reports a specific financing transaction rather than periodic financial performance metrics (e.g., revenue, net income, or operating cash flow). The filing text does not provide a clear value for these operational metrics.
| Metric | Value |
|---|---|
| Principal Amount Raised (Notes) | $807,000 |
| Interest Rate | 11% per annum |
| Warrants Issued | 1,614,000 shares |
| Warrant Exercise Price | $0.30 per share |
| Warrant Term | 5 years |
| Note Maturity | 3 years from issuance |
Material Changes and Transaction Details
On June 3, 2016, the Company entered into a Note and Warrant Purchase Agreement with accredited investors. Key terms include:
- Debt Structure: The Notes are unsecured and bear interest payable semi-annually in cash. The entire principal and accrued interest are due on the third anniversary. The Company may prepay without penalty.
- Default Provisions: An "Event of Default" includes failure to pay, bankruptcy proceedings, or the sale of the Company, allowing holders to declare the full amount immediately due.
- Registration Rights: Purchasers were granted "piggy-back" registration rights for shares issuable upon warrant exercise.
- Related Party Transactions:
- PoC Capital, LLC (owned by CEO Daron Evans and his minor children) purchased $30,000 of Notes and warrants for 60,000 shares.
- Lambda Investors LLC purchased $300,000 of Notes and warrants for 600,000 shares. Lambda beneficially owned approximately 64% of the Company's outstanding common stock prior to this transaction.
Guidance, Risks, and Contingencies
Regulatory Status: The offer and sale constituted a private placement under Section 4(2) of the Securities Act of 1933 and Regulation D.
Documentation: Complete copies of the Note, Warrant, and Purchase Agreement are to be filed with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, or via amendment to this Form 8-K.
Risks: The filing highlights the risk of an "Event of Default" triggering immediate repayment obligations. The significant ownership concentration by Lambda Investors (64%) prior to the transaction represents a material corporate governance factor.
Investor Verification Checklist
- Verify the full text of the Note and Warrant Purchase Agreement once filed in the upcoming Form 10-Q to review specific covenants and default triggers.
- Confirm the current cash position of the Company to assess its ability to meet semi-annual interest payments on the new $807,000 debt.
- Review the updated capitalization table to understand the potential dilution from the 1,614,000 warrants if exercised at $0.30 per share.
- Monitor the relationship and voting power of Lambda Investors LLC, given its 64% pre-transaction ownership and connection to Company directors.